恩华药业：自主研发的NH140068片获批开展用于精神分裂症的临床试验
恩华药业宣布收到1类化学药品NH140068片的《药物临床试验批准通知书》，该药为新一代治疗精神分裂症的创新药，具有改善阳性和阴性症状且副作用小的潜力。公司将按要求开展临床试验，待成功后申报生产批件，进一步丰富精神类药品产品线。
媒体报道
恩华药业1类创新药NH140068获批临床！批准开展用于精神分裂症的临床试验 医药魔方
精神分裂症新药获批临床！恩华药业管线上新 医药魔方
恩华药业：自主研发的NH140068片获批开展用于精神分裂症的临床试验 财经网
#热门话题
BY Readhub
That growth environment will include rising inflation and interest rates. Those upward shifts naturally accompany healthy growth periods as the demand for resources, products and services rise. Importantly, the Federal Reserve has laid out the rationale for not interfering with that natural growth transition.It's not exactly a fad, but there is a widespread willingness to pay up for a growth story. Classic fundamental analysis takes a back seat. Even negative earnings are ignored. In fact, positive earnings seem to be a limiting measure, producing the question, "Is that all you've got?" The preference is a vision of untold riches when the exciting story plays out as expected.
Bitcoin is a decentralized digital currency that you can buy, sell and exchange directly, without an intermediary like a bank. Bitcoin’s creator, Satoshi Nakamoto, originally described the need for “an electronic payment system based on cryptographic proof instead of trust.” Each and every Bitcoin transaction that’s ever been made exists on a public ledger accessible to everyone, making transactions hard to reverse and difficult to fake. That’s by design: Core to their decentralized nature, Bitcoins aren’t backed by the government or any issuing institution, and there’s nothing to guarantee their value besides the proof baked in the heart of the system. “The reason why it’s worth money is simply because we, as people, decided it has value—same as gold,” says Anton Mozgovoy, co-founder & CEO of digital financial service company Holyheld.
Readhub from us